Ubie, Japanese Health-Tech Startup, Raises $26.2 Million In Series C, $59.8 Million In Total
Amount Raised
$26.2 Million
Round Type
Series C
JapanBiotechnologyHealth CareArtificial IntelligenceMedicalDescription
Ubie, Inc., a healthcare AI startup with the mission "To develop a healthcare guide for everyone," announced that it has raised $26.2 million (*1) in the 1st round of Series C funding. New investors in the round include Norinchukin Capital Co., Ltd., NVenture Capital Limited (wholly owned subsidiary of NEC Capital Solutions Limited), The Dai-ichi Life Insurance Company, Limited, and Egg FORWARD, Inc., while existing investors include SUZUKEN CO., LTD. To date, Ubie has raised $59.8 million (*2).
Who else raised in Medical and Biotechnology around the same time
Companies in the same sectors as Ubie that raised within 45 days of this round, from Fundz verified event records.
- Optellum raised $14M (Series A) on September 27, 2022.
- Leuko raised $5M (Series A) on September 23, 2022.
- Incepto raised $27M (Funding Round) on September 19, 2022.
- FathomX raised an undisclosed amount (Pre-Series A) on September 1, 2022.
- Avenda Health, Inc. raised $10M (Series B) on August 25, 2022.
- Adastra raised an undisclosed amount on August 22, 2022.
Who to call at Ubie, and when
A new round usually means Ubie is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Ubie raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Ubie, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Ubie. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Ubie raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Ubie raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.